Plain-English translation of NCT06964685 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is watching how well the Impella CP—a small pump placed in the heart to help it pump blood during a severe heart attack—works when used alongside standard emergency care. Researchers will collect information from hospital records and follow-up visits for up to one year to understand how safe this treatment is and what happens to patients over time.
When someone has a severe heart attack that suddenly drops their blood pressure dangerously low, their heart may be too weak to pump enough blood to the body. This study exists to learn whether using this heart-support pump during emergency care helps patients survive and recover better while following standard medical guidelines.
You likely qualify if…
You likely don't qualify if…
You do not need to take any medication or do anything special for this study. Researchers will collect information from your hospital medical records during your emergency care and recovery. After you leave the hospital, you will have follow-up visits or phone check-ins at 30 days, 6 months, and 1 year to see how you are doing and gather additional health information.
AI-generated summary from trial data · Sep 21, 2026 · Not medical advice
United States